$SGYP recently had a drug approved by the FDA prior to their PDUFA date, it is clearly superior to existing drugs, and they own all of it. Then the stock tanked 10%.
What happened here? Some theories - manipulation around Jan 20 options expiry, severe diarrhea side effect (it's a goddamn laxitive drug and has much less diarrhea effect than it's competitor!) which Adam Feurstein tweeted about. Company is packaged for sale, not sales.
I'm not sure what I'm missing here. Is there any valid reason for the stock going down?
Submitted January 22, 2017 at 10:18PM by Slightly_Communist http://ift.tt/2k6AbgU
No comments:
Post a Comment